Provided by Tiger Fintech (Singapore) Pte. Ltd.

Virpax Pharmaceuticals, Inc.

0.2750
+0.01505.77%
Volume:7.13K
Turnover:2.01K
Market Cap:341.69K
PE:0.00
High:0.3000
Open:0.2550
Low:0.2550
Close:0.2600
Loading ...
Apr 03, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]
Apr 03, 2025

Major Issues Report

Form 8-K - Current report
Mar 25, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mar 21, 2025

Major Issues Report

Form 8-K - Current report
Mar 17, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Mar 04, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 06, 2025

Major Issues Report

Form 8-K - Current report
Feb 04, 2025

Major Issues Report

Form 8-K - Current report
Jan 30, 2025

Major Issues Report

Form 8-K - Current report
Jan 23, 2025

Correspondence

Form CORRESP - Correspondence
Jan 23, 2025

Correspondence

Form CORRESP - Correspondence
Jan 17, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 15, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 15, 2025

Major Issues Report

Form 8-K - Current report
Jan 07, 2025

Major Issues Report

Form 8-K - Current report
Dec 30, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dec 30, 2024

Major Issues Report

Form 8-K - Current report
Dec 18, 2024

Major Issues Report

Form 8-K - Current report
Dec 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 29, 2024

Major Issues Report

Form 8-K - Current report